Epidemiological Surveillance of the Impact of the COVID-19 Pandemic on Stroke Care Using Artificial Intelligence.

Journal: Stroke
Published Date:

Abstract

BACKGROUND AND PURPOSE: The degree to which the coronavirus disease 2019 (COVID-19) pandemic has affected systems of care, in particular, those for time-sensitive conditions such as stroke, remains poorly quantified. We sought to evaluate the impact of COVID-19 in the overall screening for acute stroke utilizing a commercial clinical artificial intelligence platform.

Authors

  • Raul G Nogueira
    Department of Neurology, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Jason M Davies
    Philip R. Lee Institute for Health Policy Studies, School of Medicine, University of California, San Francisco.
  • Rishi Gupta
    Wellstar Medical Group Neurosurgery (RG) and Neurosciences (KO), Wellstar Health System, Marietta, GA (R.G., K.O.).
  • Ameer E Hassan
    Clinical Research Department, Valley Baptist Medical Center, Harlingen, TX, USA.
  • Thomas Devlin
    Erlanger Health System, University of Tennessee Health Sciences Center, Chattanooga, TN (T.D.).
  • Diogo C Haussen
    Department of Neurology, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Mahmoud H Mohammaden
    Department of Neurology, Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Emory School of Medicine, Atlanta, GA (R.G.N., D.C.H., M.H.M., M.R.F.).
  • Christopher P Kellner
    Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, New York, USA.
  • Adam Arthur
    Department of Neurosurgery (AA) and Neurology (LE), Semmes-Murphey Clinic and University of Tennessee Health Sciences Center, Memphis (A.A., L.E.).
  • Lucas Elijovich
    From the Biocomplexity Institute (V.A., R.Z.), Department of Industrial and Systems Engineering (G.T.), and Nutritional Immunology and Molecular Medicine Laboratory, Biocomplexity Institute (R.H., J.B.-R.), Virginia Tech, Blacksburg; Biomedical and Translational Informatics Institute (V.A.) and Department of Neurology (R.Z.), Geisinger Health System, Danville, PA; Department of Neurology, University of Tennessee Health Science Center, Memphis (N.G., G.T., L.E., J.E.M., A.W.A., A.V.A., R.Z.); Second Department of Neurology, "Attikon University Hospital," School of Medicine, University of Athens, Greece (N.H.); and Neurovascular Imaging Research Core and UCLA Stroke Center, University of California, Los Angeles (D.S.L.).
  • Kumiko Owada
    Wellstar Medical Group Neurosurgery (RG) and Neurosciences (KO), Wellstar Health System, Marietta, GA (R.G., K.O.).
  • Dina Begun
    Viz.ai, Inc, Palo Alto, CA (D.B., M.N., N.M.).
  • Mukund Narayan
    Viz.ai, Inc, Palo Alto, CA (D.B., M.N., N.M.).
  • Nadia Mordenfeld
    Viz.ai, Inc, Palo Alto, CA (D.B., M.N., N.M.).
  • Wondwossen G Tekle
    Clinical Research Department, Valley Baptist Medical Center, Harlingen, TX, USA.
  • Fadi Nahab
    Department of Neurology and Pediatrics, Emory University, Atlanta, GA (F.N.).
  • Tudor G Jovin
    Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Don Frei
    Radiology Imaging Associates/RIA Neurovascular, Swedish Medical Center, Denver, CO (D.F.).
  • Adnan H Siddiqui
    2Canon Stroke and Vascular Research Center, University at Buffalo, the State University of New York, Buffalo, New York.
  • Michael R Frankel
    Department of Neurology, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, Georgia, USA.
  • J Mocco
    Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, USA.